Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schaefer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncogene|September 4, 2019
SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyondThorsten Schaefer, Claudia Lengerke
International Journal of Molecular Sciences|July 16, 2020
SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and CancerThorsten Schaefer, Rebekah Steiner, Claudia Lengerke
Environmental Science & Technology|October 22, 2002
A kinetic study of Am(III)/humic colloid interactionsRobert Artinger, Wolfram Schuessler, Thorsten Schaefer, et al.
Chemical Science|January 26, 2024
Correction: A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3KαWerner Theodor Jauslin, Matthias Schild, Thorsten Schaefer, et al.
Chemical Science|January 5, 2024
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3KαWerner Theodor Jauslin, Matthias Schild, Thorsten Schaefer, et al.
Journal of the American Chemical Society|March 30, 2022
Covalent Proximity Scanning of a Distal Cysteine to Target PI3KαChiara Borsari, Erhan Keles, Jacob A McPhail, et al.
Oncotarget|October 27, 2015
Molecular and functional interactions between AKT and SOX2 in breast carcinomaThorsten Schaefer, Hui Wang, Perihan Mir, et al.
Blood|November 23, 2020
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicingChristoph Schürch, Thorsten Schaefer, Joëlle S Müller, et al.
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.
European Journal of Medicinal Chemistry|January 12, 2023
Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitorMartina De Pascale, Lukas Bissegger, Chiara Tarantelli, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncogene|September 4, 2019
SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyondThorsten Schaefer, Claudia Lengerke
International Journal of Molecular Sciences|July 16, 2020
SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and CancerThorsten Schaefer, Rebekah Steiner, Claudia Lengerke
Environmental Science & Technology|October 22, 2002
A kinetic study of Am(III)/humic colloid interactionsRobert Artinger, Wolfram Schuessler, Thorsten Schaefer, et al.
Chemical Science|January 26, 2024
Correction: A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3KαWerner Theodor Jauslin, Matthias Schild, Thorsten Schaefer, et al.
Chemical Science|January 5, 2024
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3KαWerner Theodor Jauslin, Matthias Schild, Thorsten Schaefer, et al.
Journal of the American Chemical Society|March 30, 2022
Covalent Proximity Scanning of a Distal Cysteine to Target PI3KαChiara Borsari, Erhan Keles, Jacob A McPhail, et al.
Oncotarget|October 27, 2015
Molecular and functional interactions between AKT and SOX2 in breast carcinomaThorsten Schaefer, Hui Wang, Perihan Mir, et al.
Blood|November 23, 2020
SRP54 mutations induce congenital neutropenia via dominant-negative effects on XBP1 splicingChristoph Schürch, Thorsten Schaefer, Joëlle S Müller, et al.
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.
European Journal of Medicinal Chemistry|January 12, 2023
Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitorMartina De Pascale, Lukas Bissegger, Chiara Tarantelli, et al.
Pageof 2